Amano Enzyme
VC Fund
Nagoya, Japan
Amano Enzyme is a VC fund in Nagoya focused on Energy and Medical. Enzymes can improve functionality, flavor, and more, and we at Amano thrive on helping you make your product even better through this technology. These tiny molecules can drive incredible improvements in a product, which in turn can make a difference for humans—better food, fuel, medicine, supplements, and so much more. Let us be your creativepartner for a better product. Amano Enzyme's state-of-the-art facility for an enzyme company is constructed and housed to meet high quality standards. Temperature, humidity, and pressure are controlled, monitored, and recorded using an advanced and robust environmental monitoring system. room temperature and cold storage warehouses. They have manufacturing and clean room facilities.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Amano Enzyme invests in
Stages Amano Enzyme invests in
Countries Amano Enzyme invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Amano Ennosuke
|
|||
Motoyuki Amano
|
|||
Investment Focus
Industry
- Energy 1 (50%)
- Medical 1 (50%)
- Agriculture 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
Stage
- Funding Round 1 (50%)
- Venture - Series Unknown 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Amano Ennosuke
Founder
|
Founder | Total investments: 0 | Find email | |
|
Motoyuki Amano
President and CEO
|
President and CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Chitose Group
|
CHITOSE GROUP is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. CHITOSE GROUP is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technologicaldevelopment capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology”. | $28.6M / Venture - Series Unknown / Mar 10, 2025 | |
|
Chitose Group
|
CHITOSE GROUP is a family of biotechnology companies operating mainly in Southeast Asia and Japan with an aim of leaving mankind with an environment where they can live in abundance for over a thousand years. CHITOSE GROUP is creating new values in the fields of agriculture, medical, food, energy, chemistry and others through “Technologicaldevelopment capabilities in the biotechnology field by constantly promoting economic rationality” and “Business development capabilities for drawing a path towards commercialization by understanding the essence and limitations of biotechnology”. | $22.5M / Venture - Series Unknown / Jul 13, 2023 |
Co-Investors
Ikeda Saccharification Industry
2 deals together
Mers Line
2 deals together
Mitsui Mining & Smelting
2 deals together
NGK Insulators
2 deals together
Shinsho
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Amano Enzyme invest in?
Amano Enzyme invests primarily in Energy, Medical and Agriculture startups, most often at Funding Round and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Amano Enzyme?
Public channels for Amano Enzyme include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Amano Enzyme?
The team at Amano Enzyme includes Amano Ennosuke (Founder) and Motoyuki Amano (President and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
